Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Tragni

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Frontiers in Pharmacology|May 13, 2022
Evaluation of Factors Associated With Appropriate Drug Prescription and Effectiveness of Informative and Educational Interventions-The EDU.RE.DRUG ProjectFederica Galimberti, Elena Olmastroni, Manuela Casula, et al.
Atherosclerosis. Supplements|February 16, 2021
Prevalence and relationship between metabolic syndrome and risk of cardiovascular disease: Evidence from two population-based studiesAsiiat S Alieva, Elena Olmastroni, Olga V Reutova, et al.
Atherosclerosis. Supplements|September 5, 2018
Epidemiology of cardiovascular risk factors in two population-based studiesElena Olmastroni, Evgeny V Shlyakhto, Aleksandra O Konradi, et al.
Pharmacoepidemiology and Drug Safety|May 4, 2026
The Contribution to the Assignment of Defined Daily Dose (DDD) to Antineoplastic Drugs of the Italian Working Group on DDDAngela Boccia, Giulia Hyeraci, Anna Girardi, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Frontiers in Pharmacology|May 13, 2022
Evaluation of Factors Associated With Appropriate Drug Prescription and Effectiveness of Informative and Educational Interventions-The EDU.RE.DRUG ProjectFederica Galimberti, Elena Olmastroni, Manuela Casula, et al.
Atherosclerosis. Supplements|February 16, 2021
Prevalence and relationship between metabolic syndrome and risk of cardiovascular disease: Evidence from two population-based studiesAsiiat S Alieva, Elena Olmastroni, Olga V Reutova, et al.
Atherosclerosis. Supplements|September 5, 2018
Epidemiology of cardiovascular risk factors in two population-based studiesElena Olmastroni, Evgeny V Shlyakhto, Aleksandra O Konradi, et al.
Pharmacoepidemiology and Drug Safety|May 4, 2026
The Contribution to the Assignment of Defined Daily Dose (DDD) to Antineoplastic Drugs of the Italian Working Group on DDDAngela Boccia, Giulia Hyeraci, Anna Girardi, et al.
Pageof 4